Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Class A Common Stock, $0.0001 par value per share
-
Shares outstanding
-
99,823,000
-
Total 13F shares
-
4,033,213
-
Share change
-
-2,425,419
-
Total reported value
-
$2,015,817
-
Price per share
-
$0.50
-
Number of holders
-
36
-
Value change
-
-$1,258,446
-
Number of buys
-
13
-
Number of sells
-
13
Institutional Holders of Rani Therapeutics Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (RANI) as of Q3 2025
As of 30 Sep 2025,
Rani Therapeutics Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (RANI) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,033,213 shares.
The largest 10 holders included
VANGUARD GROUP INC, Nan Fung Group Holdings Ltd, CITADEL ADVISORS LLC, UNITED SERVICES AUTOMOBILE ASSOCIATION, GEODE CAPITAL MANAGEMENT, LLC, KESTRA PRIVATE WEALTH SERVICES, LLC, TAKEDA PHARMACEUTICAL CO LTD, CWA Asset Management Group, LLC, BlackRock, Inc., and HRT FINANCIAL LP.
This page lists
36
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.